Qualisure Diagnostics Inc. develops molecular tests that enhance cancer care by identifying features that help oncologists to personalize treatments. Each of our biomarkers is designed to influence clinical decision-making and to facilitate Precision Medicine.
Understanding which cancers are indolent or aggressive, and which ones are more likely to respond to certain treatments can guide an oncologist to recommend a treatment strategy that is optimized for each patient. Our precision diagnostics – discovered using our own machine learning algorithms – minimize the burden of cancer treatment by avoiding toxic and costly treatments that are unlikely to provide benefit.
